Gene therapy

uniQure announced it has received approval from the European Commission for the gene therapy Glybera®, a treatment for patients with lipoprotein lipase deficiency (LPLD, also called familial hyperchylomicronemia) suffering from recurring acute pancreatitis. The approval makes Glybera the first gene therapy approved by regulatory authorities in the Western world.